日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

chinadaily.com.cn
left corner left corner
China Daily Website

Medical reforms spell out profit for pharma giants

Updated: 2013-04-13 14:37
By Liu Jie ( China Daily)

China now has 148 million people with pre-diabetes on top of an existing 92.4 million diabetes patients.

The number of patients is forecast to reach 130 million by 2030, creating medical costs related to type-2 diabetes of $47.2 billion, according to International Diabetes Federation.

In the China National Plan for Chronic Diseases Prevention and Treatment (2012-2015), diabetes has been given specific importance.

"Our advantage is in early-stage diabetes treatment. Our Glucophage (an oral diabetes medicine that helps control blood sugar levels) is recommended as initial treatment within national guidelines," said Jean-Christophe Pointeau, president of Bristol-Myers China.

The medicine is on China's essential drug list and Pointeau said he expects another Bristol-Myers product - Onglyza, a prescription type 2 diabetes medicine - also to be included.

Another major international name, Boston Scientific Co, has just announced clinical results of a trial evaluating the safety and effectiveness of a cardiovascular stent system in China.

Clinical trials are the prerequisite of new product introduction.

The US company is also working to introduce more specialist treatment to the Chinese market, including those involved in cardiology and endoscopy, especially in the treatment of chronic conditions, said Michael F. Mahoney, Boston Scientific's CEO.

Since entering China in 1997, the company's average annual growth by sales has kept at 30 percent and it expects to exceed that figure in coming years.

The company is also building a research and development, training and head office complex in Shanghai, which is expected to be completed in September.

China expects to increase its medical spending by 27 percent this year, and to more than double the number of drugs in its national reimbursement medicine list from 205 to 520.

China's medical insurance will cover an additional 20 serious illnesses, including lung and gastric cancers, chronic myelocytic leukemia, hemophilia, type-1 diabetes and cerebral infarction.

These are also other serious diseases seeing increased occurrence in China, which lack high-quality diagnosis and treatment equipment being produced by domestic companies, according to a recent report from Bank of China International (China) Ltd.

Sanofi's Lam added that so far the company cannot assess how successful its investment in the Chinese market has been, "but we believe in the long run, it will be absolutely positive to us".

Sanofi's diabetes business increased 25 percent year-on-year in 2012, compared with the average growth of the sector at 15 percent.

 
 
...
主站蜘蛛池模板: 日本在线精品视频 | 美女18毛片 | 日本不卡高字幕在线2019 | 国产精品色视频 | 免费黄色资源 | 国产一区二区在线观看视频 | 三级五月天 | 成人黄色免费观看 | 亚洲午夜久久久 | 永久黄色网址 | 亚洲综合涩 | 色人阁av | 国产一区二区免费在线观看 | 看一下毛片 | av大片免费看 | 国产精品毛片一区二区三区 | 亚洲最大av网站 | 久久久一区二区三区四区 | 天天夜夜草 | 国产精品久久久久久在线观看 | 午夜影院免费体验区 | 国产精品第十页 | 性欧美ⅴideo另类hd | 国产传媒在线看 | 国产黄色精品视频 | 欧美肥老妇视频九色 | 在线免费观看成年人视频 | 亚洲免费在线视频 | 久久丝袜视频 | 91视频麻豆 | 黄色在线网 | 日本一区二区中文字幕 | 国产午夜精品一区二区三区嫩草 | 午夜视频在线观看网站 | 金8天国av| 在线观看黄色av | 成人深夜免费视频 | 91在线免费视频观看 | 麻豆国产91在线播放 | 亚洲一区二区视频 | 九九精品免费视频 |